Phase I/II Study of HCW9218 in Patients with Advanced Pancreatic Cancer
The purpose of this phase I/II study is to evaluate the safety and tolerability of HCW9218 in patients with advanced pancreatic adenocarcinoma.
Study ID: HCWPAN102
Trial Phase: Phase I/II
Trial Sponsor: HCW Biologics
Therapies Used in This Trial: